Top Biopharmas Such As Abbott And GlaxoSmithKline Still Betting On "Messed Up" Indian Drugs Market

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Global drugmakers have had a nauseous time in India's $14 billion market. Prices have dropped and valuable patents have been overruled as the authorities strive to make medicines affordable for the 70 percent of people living on less than $2 a day. From a regulatory perspective, the government has "messed up", as one top industry consultant put it.

Help employers find you! Check out all the jobs and post your resume.

Back to news